Drawing for CVS SPECIALTY

USPTO serial 90141204

CVS SPECIALTY

Reviewed by CopyMark Law Group

Reg. 6570593Status 700Renewal
Filing date
Status date
Registration date
Nov 23, 2021
Examiner
YOUNG, THOMAS PAUL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CVS SPECIALTY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erich G. Rhynhart

ONE CVS DRIVEMAILCODE: 1160WOONSOCKET, RI 02895

Goods and services

ClassDescriptionStatusFirst use
035Business administrative services for medical referrals; managed care services, namely, electronic processing of health care and pharmaceutical information; procurement, namely, purchasing pharmaceuticals for others; supplying prescription drugs to health plan participants for the funding organizationsACTIVEAug 29, 2016
036Insurance claims administration for medical claims and pharmaceuticals; processing of insurance claims and payment dataACTIVEMar 15, 2017
041Medical educational services, namely, providing courses of instruction in the medical fields of parenteral and enteral therapy and intraperitoneal therapy and treatment; medical education services, namely, training for medical professionals and patients regarding the use and application of enteral and parenteral therapy for medical purposes and distributing course materials in connection therewith; medical educational services, namely, providing individualized and group instruction, seminars and workshops for patients and caregivers of patients requiring parenteral and enteral therapy for medical purposesACTIVEDec 31, 2016
044Medical services, namely, providing therapy management services relating to the provision of in-home and ambulatory infusion therapies and nutritional services; Medical services, namely, infusion services provided at home and in clinics; nursing services; providing medical information concerning hemophilia; Providing in-home and ambulatory dispensing and administering of infusion pharmaceuticals, and providing hemophilia, anti-infectives, pain remediation, palliative care, cardiac, inotropic, antitrypsin deficiency, pre-transplant, post-transplant, growth hormone, hepatitis, osteoarthritis, steroid, immune deficiency, rheumatoid arthritis, multiple sclerosis, interferon, alcohol dependency, oncology, fertility, vaccine and nutritional therapy servicesACTIVEMar 15, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Nov 23, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 16, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 15, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 13, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE
Oct 13, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 30, 2021IUAFUSE AMENDMENT FILED
Sep 30, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 6, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2021XAECEXAMINER'S AMENDMENT ENTERED
Jan 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Jan 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Jan 4, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2020DOCKASSIGNED TO EXAMINER
Oct 1, 2020MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 30, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2020NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance